Elevance Health Inc. Stock Advances 5.4%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Elevance Health Inc. advanced 5.4% to $416.54 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,591.70 and Dow Jones Industrial Average falling 0.6% to 52,064.10.

The stock's rise snapped a three-day losing streak.

Elevance Health Inc. closed 4.5% below its 52-week high of $436.24, which the company reached on July 14th.

The stock outperformed some of its peers, as UnitedHealth Group Inc. fell 1.2% to $388.28, Cigna Group rose 1.0% to $280.91, and Humana Inc. rose 0.18% to $400.73.

Trading volume totaled 1.9 million, compared to the 50-day average of 1.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 10, 2026 16:34 ET (20:34 GMT)